Similar articles for PMID: 31621633

Year	Number of Results
1989	2
1993	1
1994	2
1995	1
1996	3
1997	1
1998	3
1999	1
2000	1
2001	1
2002	2
2003	1
2004	1
2005	3
2009	3
2010	1
2011	1
2012	3
2013	2
2015	3
2016	1
2017	3
2018	9
2019	16
2020	22
2021	17
2022	3
2023	1
2024	0

1

Selection of Biologics for Severe Type-2 Asthma.

Yilmaz I. Yilmaz I. J Investig Allergol Clin Immunol. 2019 Oct;29(5):399-400. doi: 10.18176/jiaci.0414. J Investig Allergol Clin Immunol. 2019. PMID: 31621633 Free article. No abstract available.

2

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.

Detoraki A, Tremante E, D'Amato M, Calabrese C, Casella C, Maniscalco M, Poto R, Brancaccio R, Boccia M, Martino M, Imperatore C, Spadaro G. Detoraki A, et al. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211009398. doi: 10.1177/17534666211009398. Ther Adv Respir Dis. 2021. PMID: 33910399 Free PMC article.

3

Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient.

Ogata Y, Okinaka Y, Takahashi M. Ogata Y, et al. Rhinology. 1999 Mar;37(1):16-20. Rhinology. 1999. PMID: 10229976

4

Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.

Tversky J, Lane AP, Azar A. Tversky J, et al. Clin Exp Allergy. 2021 Jun;51(6):836-844. doi: 10.1111/cea.13852. Epub 2021 Feb 27. Clin Exp Allergy. 2021. PMID: 33595845 Clinical Trial.

5

Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.

Latorre M, Bacci E, Seccia V, Bartoli ML, Cardini C, Cianchetti S, Cristofani L, Di Franco A, Miccoli M, Puxeddu I, Celi A, Paggiaro P. Latorre M, et al. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620965151. doi: 10.1177/1753466620965151. Ther Adv Respir Dis. 2020. PMID: 33263506 Free PMC article.

6

Eosinophil paradox with mepolizumab in chronic rhinosinusitis with nasal polyposis.

Lipworth B, Chan R, RuiWen Kuo C. Lipworth B, et al. J Allergy Clin Immunol. 2020 Sep;146(3):683. doi: 10.1016/j.jaci.2020.05.054. Epub 2020 Jul 24. J Allergy Clin Immunol. 2020. PMID: 32713686 No abstract available.

7

The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.

Patel GB, Peters AT. Patel GB, et al. Ear Nose Throat J. 2021 Jan;100(1):44-47. doi: 10.1177/0145561320964653. Epub 2020 Oct 9. Ear Nose Throat J. 2021. PMID: 33035132 Free PMC article.

8

Activated eosinophils in nasal polyps: a comparison of asthmatic and non-asthmatic patients.

Bateman ND, Shahi A, Feeley KM, Woolford TJ. Bateman ND, et al. Clin Otolaryngol. 2005 Jun;30(3):221-5. doi: 10.1111/j.1365-2273.2005.00969.x. Clin Otolaryngol. 2005. PMID: 16111416

9

Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3.

Saito H, Honda K, Asaka C, Ueki S, Ishikawa K. Saito H, et al. Allergol Int. 2016 Jul;65(3):280-5. doi: 10.1016/j.alit.2016.01.001. Epub 2016 Feb 10. Allergol Int. 2016. PMID: 26874579 Free article.

10

Biologics for chronic rhinosinusitis.

Chong LY, Piromchai P, Sharp S, Snidvongs K, Webster KE, Philpott C, Hopkins C, Burton MJ. Chong LY, et al. Cochrane Database Syst Rev. 2021 Mar 12;3(3):CD013513. doi: 10.1002/14651858.CD013513.pub3. Cochrane Database Syst Rev. 2021. PMID: 33710614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year